124 related articles for article (PubMed ID: 38813301)
1. COVID-19 Vaccination Rates and Predictors of Vaccine Uptake Among Adults With Chronic Obstructive Pulmonary Disease: Insights From the 2022 National Health Interview Survey.
Fasehun OO; Adedoyin O; Iheagwara C; Ofuase-Lasekan IH; Manandhar S; Akoto NA; Ajani T; Nwume CG; Green JT; Okobi OE
Cureus; 2024 Apr; 16(4):e59230. PubMed ID: 38813301
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Vaccination Rates and Predictors of Uptake Among Adults With Coronary Heart Disease: Insight From the 2022 National Health Interview Survey.
Ezeamii VC; Ofochukwu VC; Iheagwara C; Asibu T; Ayo-Farai O; Gebeyehu YH; Kaglo EO; Odoeke MC; Adeyemi OM; Shittu HO; Okobi OE
Cureus; 2024 Jan; 16(1):e52480. PubMed ID: 38371067
[TBL] [Abstract][Full Text] [Related]
3. First booster dose uptake of COVID-19 vaccine and disease-related factors in chronic obstructive pulmonary disease-a cross-sectional survey in Hungary.
Fekete M; Horvath A; Santa B; Tomisa G; Szollosi G; Varga JT
Ann Palliat Med; 2023 May; 12(3):516-528. PubMed ID: 37038057
[TBL] [Abstract][Full Text] [Related]
4. Sociodemographic inequities in COVID-19 vaccination among adults in the United States, 2022.
Guadamuz JS
J Am Pharm Assoc (2003); 2024; 64(3):102064. PubMed ID: 38432482
[TBL] [Abstract][Full Text] [Related]
5. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
[TBL] [Abstract][Full Text] [Related]
6. Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System.
Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Xie F; Ackerson BK; Takhar H; Ogun OA; Simmons S; Zamparo JM; Tseng HF; Jodar L; McLaughlin JM
JAMA Netw Open; 2023 Jan; 6(1):e2251833. PubMed ID: 36662525
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
Luk TT; Lui JHT; Wang MP
J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
Khezri M; McKnight C; Weng CA; Kimball S; Des Jarlais D
PLoS One; 2024; 19(5):e0303394. PubMed ID: 38743729
[TBL] [Abstract][Full Text] [Related]
9. Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022.
Agaku IT; Adeoye C; Long TG
JAMA Netw Open; 2022 Aug; 5(8):e2227680. PubMed ID: 35984657
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
[TBL] [Abstract][Full Text] [Related]
11. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Agrawal U; Bedston S; McCowan C; Oke J; Patterson L; Robertson C; Akbari A; Azcoaga-Lorenzo A; Bradley DT; Fagbamigbe AF; Grange Z; Hall ECR; Joy M; Katikireddi SV; Kerr S; Ritchie L; Murphy S; Owen RK; Rudan I; Shah SA; Simpson CR; Torabi F; Tsang RSM; de Lusignan S; Lyons RA; O'Reilly D; Sheikh A
Lancet; 2022 Oct; 400(10360):1305-1320. PubMed ID: 36244382
[TBL] [Abstract][Full Text] [Related]
12. Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?
Sujarwoto S; Maharani A
Front Public Health; 2023; 11():1203550. PubMed ID: 37351094
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
14. Understanding low COVID-19 booster uptake among US adults.
Jacobs ET; Cordova-Marks FM; Farland LV; Ernst KC; Andrews JG; Vu S; Heslin KM; Catalfamo C; Chen Z; Pogreba-Brown K
Vaccine; 2023 Oct; 41(42):6221-6226. PubMed ID: 37666694
[TBL] [Abstract][Full Text] [Related]
15. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():986916. PubMed ID: 36589991
[TBL] [Abstract][Full Text] [Related]
16. Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment.
Hayes KN; Harris DA; Zullo AR; Chachlani P; Wen KJ; Smith-Ray RL; Djibo DA; McCarthy EP; Pralea A; Singh TG; McMahill-Walraven C; Taitel MS; Deng Y; Gravenstein S; Mor V
Front Public Health; 2023; 11():1243958. PubMed ID: 37637796
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA
MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
[TBL] [Abstract][Full Text] [Related]
20. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
